Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuling Wu

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
BMJ Open Respiratory Research|December 3, 2025
Association of respiratory symptom profiles with future exacerbations and lung function decline in mild-to-moderate COPDHuajing Yang, Shiying Fang, Yuqiong Yang, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 19, 2012
Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assaysRobert J Kubiak, Lanju Zhang, Jianchun Zhang, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumorsLillian Siu, Joshua Brody, Shilpa Gupta, et al.
Journal of Clinical Microbiology|November 14, 2014
Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremiaBatu K Sharma-Kuinkel, Yuling Wu, David E Tabor, et al.
Leukemia & Lymphoma|October 15, 2024
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myelomaMeletios A Dimopoulos, Magdalini Migkou, Manisha Bhutani, et al.
Molecular Cancer Therapeutics|May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive CellsRuoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
Cancer Immunology, Immunotherapy : CII|April 4, 2023
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumorsJohanna Bendell, Patricia LoRusso, Michael Overman, et al.
Cancer Research|December 2, 2024
Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma ProgressionCaren Yu-Ju Wu, Yiyun Chen, Ya-Jui Lin, et al.
Mabs|August 29, 2024
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine releaseJohn S Schardt, Even Walseng, Kim Le, et al.
Neurourology and Urodynamics|February 26, 2026
Assessment of the Therapeutic Efficacy of Acupuncture in Treating Postpartum Urinary Retention: A Comprehensive Approach Integrating Systematic Review and Association Rule AnalysisXi Ye, Yuling Wu, Tian Le, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
BMJ Open Respiratory Research|December 3, 2025
Association of respiratory symptom profiles with future exacerbations and lung function decline in mild-to-moderate COPDHuajing Yang, Shiying Fang, Yuqiong Yang, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 19, 2012
Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assaysRobert J Kubiak, Lanju Zhang, Jianchun Zhang, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumorsLillian Siu, Joshua Brody, Shilpa Gupta, et al.
Journal of Clinical Microbiology|November 14, 2014
Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremiaBatu K Sharma-Kuinkel, Yuling Wu, David E Tabor, et al.
Leukemia & Lymphoma|October 15, 2024
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myelomaMeletios A Dimopoulos, Magdalini Migkou, Manisha Bhutani, et al.
Molecular Cancer Therapeutics|May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive CellsRuoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
Cancer Immunology, Immunotherapy : CII|April 4, 2023
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumorsJohanna Bendell, Patricia LoRusso, Michael Overman, et al.
Cancer Research|December 2, 2024
Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma ProgressionCaren Yu-Ju Wu, Yiyun Chen, Ya-Jui Lin, et al.
Mabs|August 29, 2024
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine releaseJohn S Schardt, Even Walseng, Kim Le, et al.
Neurourology and Urodynamics|February 26, 2026
Assessment of the Therapeutic Efficacy of Acupuncture in Treating Postpartum Urinary Retention: A Comprehensive Approach Integrating Systematic Review and Association Rule AnalysisXi Ye, Yuling Wu, Tian Le, et al.
Pageof 14